JZ

Johannes Zanzinger

Member Board Of Directors at Centauri Therapeutics Limited

Ulm, Baden-Württemberg

Overview

Work Experience

UU

Ulm University

  • Professor (apl) of Physiology

    2011 - Current

CT

Centauri Therapeutics Limited

  • Member Board Of Directors

    2022

D

DiogenX

  • Member Board Of Directors

    2020

HG

HepaRegeniX GmbH

  • Member Board Of Directors

    2019

BI

Boehringer Ingelheim

  • Investor @ BI Venture Fund

    2019

  • Global Head, Business Development & Licensing CardioMetabolic Diseases

    2009 - 2019

  • Head, Licensing Metabolic Diseases

    2005 - 2009

  • Senior Principal Scientist, R&D Coordination

    2002 - 2005

AT

AgomAb Therapeutics

  • Board Observer

    2021 - 2023

EYEVENSYS

  • Member Board Of Directors

    2019 - 2023

ML

Metabomed Ltd.

  • Member Board Of Directors

    2020 - 2021

P

Pfizer

  • Senior Principle Scientist

    1999 - 2002

    Discovery Research, in vivo Pharmacology

Uo

University of Heidelberg

  • Associate Professor of Physiology

    1993 - 1999

Education

Investments

DiogenX

Seed

Total Funding: $42M

Centauri Therapeutics

Series A

Total Funding: $33M

Relevant Websites